Clinical Trials
28 trialsNCT03910660 2026-05-15
A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
BioXcel Therapeutics Inc
Phase 1/2 Completed
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT03554473 2025-05-09
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT02489903 2025-03-17
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
EpicentRx, Inc.
Phase 2 Completed
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT04854590 2024-07-24
IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer
AstraZeneca
Completed
NCT02164461 2024-05-20
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Advaxis, Inc.
Phase 1 Completed
NCT01642251 2023-05-06
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT01860898 2022-09-28
A Phase I Study of iPS Cell Generation From Patients With COPD
Mayo Clinic
Phase NA Completed
NCT00412880 2022-06-22
BI 2536 Second Line Monotherapy in SCLC
Boehringer Ingelheim
Phase 2 Completed
NCT00826644 2021-08-09
COMBAT
Chonnam National University Hospital
Phase 3 Completed
NCT01470248 2021-02-17
Study of Arsenic Trioxide in Small Cell Lung Cancer
Emory University
Phase 2 Completed
NCT02881125 2019-12-17
Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma
University of Washington
Phase 1 Completed
NCT03092739 2019-07-23
A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens
Hoffmann-La Roche
Completed
NCT00298896 2018-07-26
Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer
Sunesis Pharmaceuticals
Phase 2 Completed
NCT00469222 2016-02-25
Hypofractionated Radiotherapy for Small Cell Lung Cancer
AHS Cancer Control Alberta
Phase 1 Completed
NCT00126828 2016-02-24
Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer
AHS Cancer Control Alberta
Phase 1/2 Completed
NCT00469066 2016-02-24
Cone Beam CT Scanning in Lung and Bladder Cancer.
AHS Cancer Control Alberta
Completed
NCT00907569 2016-02-22
Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer
AHS Cancer Control Alberta
Phase 2 Completed
NCT00466232 2015-12-16
Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer
HealthPartners Institute
Phase 1 Completed
NCT00413075 2015-07-08
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Valerio Therapeutics
Phase 1 Completed
NCT00413322 2015-07-08
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Valerio Therapeutics
Phase 1 Completed
NCT00359359 2014-11-04
A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer
Bayer
Phase 1/2 Completed
NCT00284154 2013-03-13
Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00305942 2013-01-31
Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00294190 2012-12-10
Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00046787 2011-10-20
Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer
Astellas Pharma Inc
Phase 2 Completed
NCT00191750 2007-01-26
A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned
Eli Lilly and Company
Phase 2 Completed